Shenzhen Bioeasy Biotechnology Co.,Ltd. Posted 28.1 Million Yuan Net Loss in First Quarter of 2023

Shenzhen Bioeasy Biotechnology Co.,Ltd. (深圳市易瑞生物技术股份有限公司) (300942.SZ) reported a net loss of 28.1 million yuan in the first quarter of 2023, reversing a net profit of 114.1 million yuan for the same period in the previous year.

Meanwhile, the company posted 60.7 million yuan in revenue, down 79.4% year-on-year.

At the end of the reporting period, it had 1.2 billion yuan in total assets and 262.2 million yuan in total liabilities, with a liability-to-asset ratio of 21.8%.